Application 008848
- Type
- NDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PAMINE | METHSCOPOLAMINE BROMIDE | TABLET;ORAL | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |
| 002 | PAMINE FORTE | METHSCOPOLAMINE BROMIDE | TABLET;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N008848-001 | PAMINE | METHSCOPOLAMINE BROMIDE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | ||
| N008848-002 | PAMINE FORTE | METHSCOPOLAMINE BROMIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | N008848-001 | PAMINE | 2.5MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N008848-002 | PAMINE FORTE | 5MG | TABLET / ORAL | 2003-03-25 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2003-03-25 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N008848-001 | PAMINE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N008848-002 | PAMINE FORTE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2003-03-25 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Bryant Ranch Prepack | 4ee28ed4-daff-462c-a38b-4fd8250ed9f4 | 2026-06-30 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Bryant Ranch Prepack | 6b8ed187-d378-4c95-80e0-0d3558a7aa95 | 2026-03-13 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 26cd56db-4727-40d1-8f08-3ee899052c77 | 2026-01-05 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | PD-Rx Pharmaceuticals, Inc. | 8a14ade6-d428-4144-9037-46955f68820f | 2026-01-05 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | Unichem Pharmaceuticals (USA), Inc. | 5c74bfb0-c80a-4a86-acd1-1e3a1b20255d | 2025-12-10 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| METHSCOPOLAMINE BROMIDE | METHSCOPOLAMINE BROMIDE | i3 Pharmaceuticals, LLC | 14c0c030-e96d-4a5e-95ff-02dd78a46be3 | 2025-02-24 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
| Methscopolamine Bromide | METHSCOPOLAMINE BROMIDE | Breckenridge Pharmaceutical, Inc. | 157c1cce-bceb-4c74-8aa0-d2be9952d8f9 | 2024-01-10 | Warnings, Adverse reactions | METHSCOPOLAMINE BROMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0482 | Methscopolamine Bromide | methscopolamine bromide | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 0168-0483 | Methscopolamine Bromide | methscopolamine bromide | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 10337-061 | Pamine | methscopolamine bromide | PharmaDerm a division of Fougera Pharmaceuticals Inc. | NDA | Current |
| 10337-062 | Pamine Forte | methscopolamine bromide | PharmaDerm a division of Fougera Pharmaceuticals Inc. | NDA | Current |